# An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Carboplatin and Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer - Stage IV (VENUS-2)

> **NCT01683682** · PHASE1 · COMPLETED · sponsor: **Aktion Bronchialkarzinom e.V.** · enrollment: 8 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** BIBF 1120
- **DRUG:** Vinorelbine
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT01683682
- **Lead sponsor:** Aktion Bronchialkarzinom e.V.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2015-01
- **Final completion:** —
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2015-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01683682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01683682, "An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Carboplatin and Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer - Stage IV (VENUS-2)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01683682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*